Portage Biotech Quote - PRTG | ADVFN

S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Portage Biotech Inc (PRTG) Share Price

Portage Biotech Inc (PRTG)

7.17

0.20

(2.87%)

Closed September 26 3:00PM

Delayed by 15 minutes

7.17

0.00

( 0.00% )

Pre Market: 6:00AM

Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Current Price

7.17

Bid

7.17

Ask

7.39

Volume

226

0.00 Day's Range 0.00

2.098 52 Week Range 58.60

Market Cap

Previous Close

7.17

Open

-

Last Trade

Last Trade Time

06:30:08

Financial Volume

-

VWAP

-

Average Volume (3m)

2,474,315

Shares Outstanding

1,048,614

Dividend Yield

-

PE Ratio

-0.10

Earnings Per Share (EPS)

-71.85

Revenue

-

Net Profit

-75.34M

Portage Biotech Inc is engaged in researching and developing pharmaceutical and biotech products through to clinical proof of concept with an initial focus on unmet clinical needs. It is immune-oncology company focused on overcoming immune resistance and currently managing 10 immuno-oncology assets ... Portage Biotech Inc is engaged in researching and developing pharmaceutical and biotech products through to clinical proof of concept with an initial focus on unmet clinical needs. It is immune-oncology company focused on overcoming immune resistance and currently managing 10 immuno-oncology assets at various development stages. Its pipeline products include IMM-60; IMM60 + Cell Therapy; (IMM60 / NY-ESO-1) + Keytruda and others. Show more

Sector

Pharmaceutical Preparations

Industry

Crude Petroleum & Natural Gs

Website

www.portagebiotech.com/

Headquarters

Road Town, Tortola, Vgb

Founded

2012

Portage Biotech Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker PRTG. The last closing price for Portage Biotech was US$7.17. Over the last year, Portage Biotech shares have traded in a share price range of US$ 2.098 to US$ 58.60.

Portage Biotech currently has 1,048,614 shares outstanding. The market capitalization of Portage Biotech is US$7.52 million. Portage Biotech has a price to earnings ratio (PE ratio) of -0.10.

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

Form EFFECT - Notice of Effectiveness

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Portage Biotech Reports Results for Fiscal Quarter Ended June 30, 2024 and Business Update

WESTPORT, Conn., Aug. 27, 2024 (GLOBE NEWSWIRE) -- Portage Biotech Inc. (“Portage” or the “Company”) (NASDAQ: PRTG), a clinical-stage immuno-oncology company with a portfolio of novel...

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Portage Biotech Reports Fiscal Year-Ended March 31, 2024 Financial Results and Business Update

Exploration and evaluation of strategic alternatives continuePausing patient enrollment in the ADPORT-601 clinical trial (adenosine 2A and 2B inhibitors)Discontinuing the iNKT clinical trial for...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-2.92	-28.9395441031	10.09	10.66	6.8	194534	7.99917468	CS
4	2.62	57.5824175824	4.55	23.01	2.81	2976698	9.70400366	CS
12	3.65	103.693181818	3.52	23.01	2.098	2474315	6.79651889	CS
26	-3.43	-32.358490566	10.6	23.01	2.098	1343974	6.70406925	CS
52	-36.83	-83.7045454545	44	58.6	2.098	698603	7.18353362	CS
156	-422.83	-98.3325581395	430	479.8	2.098	248880	16.81019899	CS
260	-742.83	-99.044	750	899.526	2.098	214694	31.5283544	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
ONCOOnconetix Inc	US$ 6.06 (80.60%)	4.3M
CNEYCN Energy Group Inc	US$ 0.8123 (40.08%)	5.93M
DUOFangDD Network Group Ltd	US$ 1.47 (37.38%)	17.39M
RGFReal Good Food Company Inc	US$ 0.4903 (32.51%)	3.18M
ESTAEstablishment Labs Holdings Inc	US$ 52.47 (27.37%)	38.42k
HLPHongil Group Inc	US$ 0.905 (-49.86%)	9
NVNOenVVeno Medical Corporation	US$ 3.75 (-16.67%)	28.19k
AYTUAYTU BioPharma Inc	US$ 2.39 (-16.11%)	2.82k
MNTSMomentus Inc	US$ 0.45 (-16.04%)	184.85k
AIFFFirefly Neuroscience Inc	US$ 2.52 (-16.00%)	1.59k
XPONExpion360 Inc	US$ 0.0773 (20.03%)	31.01M
DUOFangDD Network Group Ltd	US$ 1.47 (37.38%)	17.39M
CDIOCardio Diagnostics Holdings Inc	US$ 0.2934 (17.36%)	9.71M
CNEYCN Energy Group Inc	US$ 0.8123 (40.08%)	5.93M
ONCOOnconetix Inc	US$ 6.06 (80.60%)	4.3M

glenn1919

glenn1919 1 week ago

prtg.......................https://stockcharts.com/h-sc/ui?s=PRTG&p=W&b=5&g=0&id=p86431144783

Invest-in-America

Invest-in-America 1 week ago

PRTG: Halted?? (Can't go to JUPITER too quickly, ya know!!)

Invest-in-America

Invest-in-America 1 week ago

PRTG: "Silly Rabbits", indeed!!! (And below is how anyone can PICK these monster daily runners!!!)

Just be sure you DON'T pull a 'bear' out of it, like above!!! (Metaphorically speaking, that is.)
///////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////

Awl416

Awl416 1 week ago

Wonder what price that offering will be when’s it get dropped…

Invest-in-America

Invest-in-America 1 week ago

PRTG: 6-bagger-of-the-day, coming.

Awl416

Awl416 1 week ago

Invest-in-America

Invest-in-America 1 week ago

PRTG: Don't blink.

Awl416

Awl416 1 week ago

glenn1919

glenn1919 1 week ago

PRTG..............................https://stockcharts.com/h-sc/ui?s=PRTG&p=W&b=5&g=0&id=p86431144783

Monksdream

Monksdream 4 weeks ago

da_stock_analyst

da_stock_analyst 1 month ago

#PRTG 🔥 very small float! crazy move potential! keep an eye on $PRTG

boston127

boston127 1 month ago

Good DD. Thanks. EOM

Monksdream

Monksdream 1 month ago

PRTG 10Q due AUGUST 28

Monksdream

Monksdream 1 month ago

PRTG did a 1 for 20 reverse split on AUGUST 15
Today’s wash trade rally was impressive
I doubt there will be a follow through on MONDAY for this financially troubled med tech company

glenn1919

glenn1919 1 month ago

PRTG.................................https://stockcharts.com/h-sc/ui?s=PRTG&p=W&b=5&g=0&id=p86431144783

Awl416

Awl416 1 month ago

tw0122

tw0122 1 month ago

Small volume doubles pump time

Awl416

Awl416 1 month ago

The ole post reverse spilt pop

The GidDy uP Kid

The GidDy uP Kid 2 months ago

PRTG .2291… Daily psar flipped to the Bullish side, on a daily Bullish Engulfing candle, on the second largest volume day ever, with the afternoon volume surge…
https://schrts.co/wSjAWysy

glenn1919

glenn1919 2 months ago

PRTG.................................................https://stockcharts.com/h-sc/ui?s=PRTG&p=W&b=5&g=0&id=p86431144783

The GidDy uP Kid

The GidDy uP Kid 2 months ago

The GidDy uP Kid

The GidDy uP Kid 2 months ago

urge2surge

urge2surge 2 months ago

Above 50 ma. Poised to rocket.

The GidDy uP Kid

The GidDy uP Kid 3 months ago

PRTG… Daily Bullish Engulfing candle…
https://schrts.co/ZedPRivU

The GidDy uP Kid

The GidDy uP Kid 3 months ago

PRTG .1480 close, .1626 after hours… setting uP a Bullish Morning staR…
https://schrts.co/bnzvhgAs

The GidDy uP Kid

The GidDy uP Kid 3 months ago

PRTG .1480 close, .1626 after hours… setting uP a Bullish Morning staR…
https://schrts.co/bnzvhgAs

stressfreeliving

stressfreeliving 3 months ago

What are the targets?

The GidDy uP Kid

The GidDy uP Kid 3 months ago

PRTG… Portage Biotech… July 1st
https://www.globenewswire.com/news-release/2024/07/01/2906988/0/en/Advanced-Kidney-Cancer-Clinical-Trial-Pipeline-Experiences-Momentum-DelveInsight-Estimates-a-Diverse-Pipeline-Comprising-50-Companies-Working-in-the-Domain.html

The GidDy uP Kid

The GidDy uP Kid 3 months ago

Monksdream

Monksdream 4 months ago

Could this be the start of a trend of steadily rising prices
Cant win if you dont bet

The Night Stalker

The Night Stalker 4 months ago

https://stockcharts.com/h-sc/ui?s=prtg&p=D&yr=0&mn=5&dy=10&id=p24986097784&listNum=23&a=1113701411

glenn1919

glenn1919 4 months ago

PRTG................https://stockcharts.com/h-sc/ui?s=PRTG&p=W&b=5&g=0&id=p86431144783

glenn1919

glenn1919 7 months ago

PRTG.........................................https://stockcharts.com/h-sc/ui?s=PRTG&p=W&b=5&g=0&id=p86431144783

Monksdream

Monksdream 7 months ago

Ugliness and failure

mauiguy2

mauiguy2 7 months ago

Monk, if you're going to take the time to post on this board, at least post the chart of the right company. You posted the chart of CLH, not PRTG.

I owned PRTG a long time ago, but still follow its progress. Lack of progress is a better word!!

Monksdream

Monksdream 7 months ago

PRTG new 52 week low

Monksdream

Monksdream 8 months ago

PRTG new 52 week low

shmully

shmully 1 year ago

Can you tell me if longtime shareholders of PRTG will be getting shares of the spinoff INTS? Thank you.

TrendTrade2016

TrendTrade2016 1 year ago

PRTG ready for 4.72

Triple nickle

Triple nickle 1 year ago

Slow and steady

Virginia Prospector

Virginia Prospector 3 years ago

Yes, it has been rough. IMO low volume and anticipated progress setback due to covid delays caused share price to rise too fast. Then a big holder sold half their stake at $40+. Going forward I expect a slower, sustained rise driven by positive news. I did sell some on the way down but now beginning to add. The future looks bright.

mauiguy2

mauiguy2 3 years ago

Actually, it's a good letter. It's been a rough last couple of months, hasn't it, VP?

Virginia Prospector

Virginia Prospector 3 years ago

Shareholder letter gives update and roadmap for the future:
https://www.portagebiotech.com/wp-content/uploads/2021/08/Portage-PR-Shareholder-Letter-8.12.2021-FINAL.pdf

conix

conix 3 years ago

Nightroads

Nightroads 3 years ago

PRTG owns approximately 10%. Intensity Therapeutics is involved in two studies now. Phase 2 with Merck and Bristol Meyers. Phase 2 in Canada at the Ottawa Hospital. Here is the clinical study page for Intensity.

https://intensitytherapeutics.com/clinical-research/

I've been in this for quite awhile. Looks exciting over the next 30-90 days. Portage Biotech has a tremendous pipeline of drugs and the CEO and Management Team are mostly all ex-big pharma specialists. Ian Walters, the CEO is particularly worth doing some DD on.

bbhuey

bbhuey 3 years ago

I was on the stockists board and saw the info on Intensity and tumor killing properties that Portage has invested in.
Does anyone know the current size of their investment and have any further info on Intensity progress?

Virginia Prospector

Virginia Prospector 4 years ago

Portage making the right moves to advance portfolio. Watch for much progress this year.

https://longevity.technology/juvenescence-scoops-up-new-longevity-ip/

Renee

Renee 4 years ago

PTGED changed to PRTG. Moved to the Nasdaq from the OTC:

https://www.sec.gov/Archives/edgar/data/1095435/000106299321001977/exhibit99-1.htm

https://otce.finra.org/otce/dailyList?viewType=Deletions

mauiguy2

mauiguy2 4 years ago

Finally....a good update from the CEO. Nice to see. Definitely worth a read.

https://finance.yahoo.com/news/ceo-spotlight-portage-biotech-ceo-131700124.html

bbhuey

bbhuey 4 years ago

Does anyone know what catalysts are coming .

It seems that lik.this stock is taking a nap.

Portage Biotech

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions